To investigate if P2X7 agonist BzATP could increase the expression of P2X7R in U87 and U251 glioma cell lines, immunocytochemical staining and Western blot were used to determine the changes of P2X7R expression. This evidence concerns the gene P2RX7 and central nervous system cancer.